Contact Us

Popular posts from this blog

US-FDA has approved Eli Lilly and Company's new ultra rapid-acting insulin Lyumjev™ (Insulin lispro-aabc injection) for type 1 and type 2 diabetes.

Gas Leak at Maharashtra Chemical Factory, Residents Complain of Breathing Problems

How Delta variant of COVID 19 is causing disaster across the world